Transderm Scop (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Transderm Scop drug offered from Baxter Healthcare Corporation. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | Scopalamine |
| SUBSTANCE NAME: | SCOPOLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-01-01 |
| END MARKETING DATE: | 0000-00-00 |
Transderm Scop HUMAN PRESCRIPTION DRUG Details:
| Item Description | Transderm Scop from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/3d) |
| START MARKETING DATE: | 2003-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10019-553_9caea3f4-e7e2-4d24-b3b6-5e62f37b3ec8 |
| PRODUCT NDC: | 10019-553 |
| APPLICATION NUMBER: | NDA017874 |
Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers:
